iOnctura has reported immune-cell changes with roginolisib combinations in patients [...]
iOnctura will present late-breaking clinical data on roginolisib in patients [...]
Mestag Therapeutics has raised $40 million and appointed two senior [...]
iOnctura has reported immune-cell changes with roginolisib combinations in patients [...]
iOnctura will present late-breaking clinical data on roginolisib in patients [...]
Mestag Therapeutics has raised $40 million and appointed two senior [...]